DAWN vs MRNA · rev $131.2M vs rev $145.0M
Day One Biopharmaceuticals Inc (DAWN) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
DAWN currently screens at market cap $656.8M. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the DAWN and MRNA stock pages for the full models.
Not investment advice.